1. Conte A, Pizá P, Garcia-Raja A, et al. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate). Arch Esp Urol 1999;52:305-10.
2. Grases F, Costa-Bauza A. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment. Anticancer Res 1999;19:3717-22.
3. Baggio B, Gambaro G, Marchini F, et al. Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans. Lancet 1991;338:403-5.
4. Suphakarn VS, Yarnnon C, Ngunboonsri P. The effect of pumpkin seeds on oxalcrystalluria and urinary compositions of children in hyperendemic area. Am J Clin Nutr 1987;45:115-21.
5. Suphiphat V, Morjaroen N, Pukboonme I, et al. The effect of pumpkin seeds snack on inhibitors and promoters of urolithiasis in Thai adolescents. J Med Assoc Thai 1993;76:487-93.
6. Nath R, Thind SK, Murthy MSR, et al. Role of pyridoxine in oxalate metabolism. Ann NY Acad Sci 1990;585:274-84 [review].
7. Watts RW, Veall N, Purkiss P, et al. The effect of pyridoxine on oxalate dynamics in three cases of primary hyperoxaluria (with glycollic aciduria). Clin Sci 1985;69:87-90.
8. Mitwalli A, Ayiomamitis W, Grass L, Oreopoulos DG. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones. Int Urol Nephrol 1988;20:353-9.
9. Berkow R, Talbott JH, et al. The Merck Manual of Diagnosis and Therapy, 13th ed. Rahway, NJ: Merck Sharp & Dohme, 1977, 732.
10. Gershoff SN, Prien EL. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones. Am J Clin Nutr 1967;20(5)393-9.
11. Prien EL, Gershoff SF. Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi. J Urol 1974;112:509-12.
12. Johansson G, Backman U, Danielson BG, et al. Effects of magnesium hydroxide in renal stone disease. J Am Coll Nutr 1982;1:179-85.
13. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol 1999;10:840-5.
14. Ettiniger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculus recurrence but magnesium hydroxide does not. J Urol 1988;139:679-84.
15. Will EJ, Bijvoet OL. Primary oxalosis: clinical and biochemical response to high-dose pyridoxine therapy. Metabolism 1979;28:542-8.
16. Lindberg J, Harvey J, Pak CYC. Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction. J Urol 1990;143:248-51.
17. Anbazhagan M, Hariprasad C, Amudram P, et al. Effect of oral supplementation of vitamin E on urinary risk factors in patients with hyperoxaluria. J Clin Biochem Nutr 1999;27:37-47.
18. Hollingbery PW, Massey LK. Effect of dietary caffeine and sucrose on urinary calcium excretion in adolescents. Fed Proc 1986;45:375 [abstr #1280].
19. Kiel DP, Felson DT, Hannan MT, et al. Caffeine and the risk of hip fracture: the Framingham study. Am J Epidemiol 1990;132:675-84.
20. Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996;143:240-7.
21. Shuster J, Finlayson B, Scheaffer RL, et al. Primary liquid intake and urinary stone disease. J Chron Dis 1985;38:907-14.
22. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med 1998;128:534-40.
23. Lehman J Jr, Pleuss JA, Gray RW, Hoffman RG. Potassium administration increases and potassium deprivation reduces urinary calcium excretion in healthy adults. Kidney Int 1991;39:973-83.
24. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8.
25. Lee YH, Huang WC, Tsai JY, Huang JK. The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 1999;161:1453-7.
26. Breslau NA, Padalino P, Kok DJ, et al. Physicochemical effects of a new slow-release potassium phosphate preparation (UroPhos-K) in absorptive hypercalciuria. J Bone Miner Res 1995;10:394-400.
27. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med 1998;128:534-40.
28. Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996;143:240-7.
29. Pak CY. Nephrolithiasis from calcium supplementation. J Urol 1987;137:1212-3 [editorial].
30. Levine BS, Rodman JS, Wienerman S, et al. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis. Am J Clin Nutr 1994;60:592-6.
31. Seltzer MA, Low RK, McDonald M, et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol 1996;156:907-9.
32. Kang DE, Sur RL, Haleblian GE, et al. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol 2007;177:1358-62.
33. Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 1982;22:292-6.
34. Sabto J, Powell MJ, Gurr B, Gurr FW. Influence of urinary sodium on calcium excretion in normal individuals. Med J Austral 1984;140:354-6.
35. Silver J, Rubinger D, Friedlaender MM, Popovitzer MM. Sodium-dependent idiopathic hypercalciuria in renal-stone formers. Lancet 1983;ii:484-6.
36. Massey LK, Whiting SJ. Dietary salt, urinary calcium, and kidney stone risk. Nutr Rev 1995;131-9 [review].
37. Hughes J, Norman RW. Diet and calcium stones. Can Med Assoc J 1992;146:137-43 [review].
38. Sakhaee K, Harvey JA, Padalino PK, et al. The potential role of salt abuse on the risk for kidney stone formation. J Urol 1993;150(2 pt1):310-2.
39. Shuster J, Finlayson B, Scheaffer RL, et al. Primary liquid intake and urinary stone disease. J Chron Dis 1985;38:907-14.
40. Shuster J, Jenkins A, Logan C, et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol 1992;45:911-6.
41. Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996;143:240-7.
42. Robertson WG, Peacock M, Heyburn PJ, Hanes FA. Epidemiological risk factors in calcium stone disease. Scand J Urol Nephrol Supplement 1980;53:15-30.
43. Shah PJR. Unprocessed bran and its effect on urinary calcium excretion in idiopathic hypercalciuria. Br Med J 1980;281:426.
44. Ebisuno S, Morimoto S, Yoshida T, et al. Rice-bran treatment for calcium stone formers with idiopathic hypercalciuria. Brit J Urol 1986;58:592-5.
45. Massey LK, Roman-Smith H, Sutton RAL. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J Am Dietet Assoc 1993;93:901-6.
46. Massey LK, Roman-Smith H, Sutton RAL. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J Am Dietet Assoc1993;93:901-6.
47. Brinkley L, McGuire J, Gregory J, Pak CYC, et al. Bioavailability of oxalate in foods. Urology 1981;17:534.
48. Rao PN, Gordon C, Davies D, Blacklock NJ. Are stone formers maladapted to refined carbohydrates? Br J Urol 1982;54:575-7.
49. Li MK, Kavanagh JP, Prendiville V, et al. Does sucrose damage kidneys? Br J Urol 1986;58:353-7.
50. Lemann J Jr, Piering WF, Lennon EJ. Possible role of carbohydrate-induced calciuria in calcium oxalate kidney-stone formation. N Engl J Med 1969;280:232-7.
51. Gaby AR. Commentary. Nutr Healing 1996;Jan:1,10-1.
52. Piesse JW. Nutritional factors in calcium containing kidney stones with particular emphasis on vitamin C. Int Clin Nutr Rev 1985;5:110-29 [review].
53. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8.
54. Hassapidou MN, Paraskevopoulos S Th, Karakoltsidis PA, et al. Dietary habits of patients with renal stone disease in Greece. J Human Nutr Dietet 1999;12:47-51.
55. Hughes J, Norman RW. Diet and calcium stones. Can Med Assoc J 1992;146:137-43 [review].
56. Hassapidou MN, Paraskevopoulos ST, Karakoltsidis PA, et al. Dietary habits of patients with renal stone disease in Greece. J Human Nutr Dietet 1999;12:47-51.
57. Robertson WG, Peacock M, Marshall DH. Prevalence of urinary stone disease in vegetarians. Eur Urol 1982;8:334-9.
58. Hiatt RA, Ettinger B, Caan B, et al. Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol 1996;144:25-33.
59. Martini LA, Wood RJ. Should dietary calcium and protein be restricted in patients with nephrolithiasis? Nutr Rev 2000;58:111-7 [review].
60. Rao PN, Prendiville V, Buxton A, et al. Dietary management of urinary risk factors in renal stone formers. Br J Urol 1982;54:578-83.
61. Giannini S, Nobile M, Sartori L, et al. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 1999;69:267-71.
62. Ettinger B, Pak CY, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997;158:2069–73.
63. Pak CY. Medical prevention of renal stone disease. Nephron 1999;81(Suppl 1):60-5 [review].
Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Pill & refill reminders
Medication journal & mood log